LeadIQ logo
Learn more at LeadIQ.com

Insights

Loading spinner
Gathering insights about CROSSJECT…

CROSSJECT Tech Stack

CROSSJECT uses 8 technology products and services including WordPress, Open Graph, Webpack, and more. Explore CROSSJECT's tech stack below.

  • WordPress
    Content Management System
  • Open Graph
    Content Management System
  • Webpack
    Development
  • JSON-LD
    Javascript Frameworks
  • particles.js
    Javascript Graphics
  • jQuery
    Javascript Libraries
  • Django
    Web Frameworks
  • Apache
    Web Servers

CROSSJECT's Email Address Formats

CROSSJECT uses at least 1 format(s):
CROSSJECT Email FormatsExamplePercentage
F.Last@crossject.comJ.Doe@crossject.com
46%
First.Last@crossject.comJohn.Doe@crossject.com
6%
FLast@crossject.comJDoe@crossject.com
2%
F.Last@crossject.comJ.Doe@crossject.com
46%

Frequently Asked Questions

Where is CROSSJECT's headquarters located?

Minus sign iconPlus sign iconCROSSJECT's main headquarters is located at Parc MAZEN-SULLY, 6-8 rue Pauline Kergomard Dijon, Bourgogne 21000, FR. The company has employees across 3 continents, including EuropeNorth AmericaAfrica.

What is CROSSJECT's phone number?

Minus sign iconPlus sign icon You can contact CROSSJECT's main corporate office by phone at
+33-3-80-54-9****
. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is CROSSJECT's stock symbol?

Minus sign iconPlus sign iconCROSSJECT is a publicly traded company; the company's stock symbol is ALCJ.PA.

What is CROSSJECT's official website and social media links?

Minus sign iconPlus sign iconCROSSJECT's official website is crossject.com and has social profiles on LinkedInCrunchbase.

What is CROSSJECT's NAICS code?

Minus sign iconPlus sign iconCROSSJECT's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does CROSSJECT have currently?

Minus sign iconPlus sign iconAs of October 2025, CROSSJECT has approximately 97 employees across 3 continents, including EuropeNorth AmericaAfrica. Key team members include Chief Operating Officer - Specialty Pharma: O. G.Vice President Global Sales & Marketing: B. F.Vice President Global Bd&l: D. Z.. Explore CROSSJECT's employee directory with LeadIQ.

What industry does CROSSJECT belong to?

Minus sign iconPlus sign iconCROSSJECT operates in the Pharmaceutical Manufacturing industry.

What technology does CROSSJECT use?

Minus sign iconPlus sign iconCROSSJECT's tech stack includes WordPressOpen GraphWebpackJSON-LDparticles.jsjQueryDjangoApache.

What is CROSSJECT's email format?

Minus sign iconPlus sign iconCROSSJECT's email format typically follows the pattern of F.Last@crossject.com. Find more CROSSJECT email formats with LeadIQ.

When was CROSSJECT founded?

Minus sign iconPlus sign iconCROSSJECT was founded in 2001.

CROSSJECT

Pharmaceutical ManufacturingFrance51-200 Employees

Crossject SA (Euronext: ALCJ; www.crossject.com) is an emerging specialty pharma company based in France and the U.S. It is in advanced regulatory development for ZEPIZURE®, an epileptic rescue therapy, for which it was awarded a $60 million contract with the U.S. Biomedical Advanced Research and Development Authority (BARDA). ZEPIZURE® is based on the Company’s award-winning needle-free autoinjector ZENEO®, designed to enable patients and untrained caregivers to easily and instantly deliver emergency medication via intramuscular injection on bare skin or even through clothing. The Company’s other products in development include rescue therapies for allergic shocks, adrenal insufficiencies, opioid overdose and asthma attacks.

Section iconCompany Overview

Headquarters
Parc MAZEN-SULLY, 6-8 rue Pauline Kergomard Dijon, Bourgogne 21000, FR
Phone number
+33-3-80-54-9****
Website
crossject.com
Stock Symbol
ALCJ.PA
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2001
Employees
51-200

Section iconMedia & News

Section iconFunding & Financials

  • $1M$10M

    CROSSJECT's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $1M$10M

    CROSSJECT's revenue is estimated to be in the range of $1M$10M

Company Leadership

  • Stylized image of a person
    O. G.
    Chief Operating Officer - Specialty Pharma
    Phone icon
    Mobile Phone
  • Stylized image of a person
    B. F.
    Vice President Global Sales & Marketing
    Phone icon
    Mobile Phone
  • Stylized image of a person
    D. Z.
    Vice President Global Bd&l
    Phone icon
    Mobile Phone
  • Stylized image of a person
    P. A.
    Président Du Directoire (ceo)
    Phone icon
    Mobile Phone
  • Stylized image of a person
    E. B.
    Partner
    Phone icon
    Mobile Phone

Employee Directory

  • Stylized image of a person
    C. V.
    Vice President
    Phone icon
    Mobile Phone
  • Stylized image of a person
    O. L.
    Director - Pharmaceutical Development
    Phone icon
    Mobile Phone
  • Stylized image of a person
    I. L.
    Quality & Regulatory Director / Qualified Person
    Phone icon
    Mobile Phone
  • Stylized image of a person
    H. B.
    Business Development Manager
    Phone icon
    Mobile Phone
  • Stylized image of a person
    C. M.
    Clinical Project Manager
    Phone icon
    Mobile Phone

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.